BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31306078)

  • 1. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach.
    Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY
    Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Kasai T; Tokuda T; Ishii R; Ishigami N; Tsuboi Y; Nakagawa M; Mizuno T; El-Agnaf OM
    J Neurol; 2014 Jun; 261(6):1203-9. PubMed ID: 24737170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases.
    Rohan Z; Smetakova M; Kukal J; Rusina R; Matej R
    BMC Neurol; 2015 Mar; 15():50. PubMed ID: 25886404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
    J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.
    Llorens F; Kruse N; Karch A; Schmitz M; Zafar S; Gotzmann N; Sun T; Köchy S; Knipper T; Cramm M; Golanska E; Sikorska B; Liberski PP; Sánchez-Valle R; Fischer A; Mollenhauer B; Zerr I
    Mol Neurobiol; 2018 Mar; 55(3):2249-2257. PubMed ID: 28321768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
    J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
    Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.
    Singh A; Beveridge AJ; Singh N
    PLoS One; 2011 Mar; 6(3):e16804. PubMed ID: 21408069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S
    Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt-Jakob disease in clinical practice.
    Fayolle M; Lehmann S; Delaby C
    J Neural Transm (Vienna); 2022 Feb; 129(2):133-139. PubMed ID: 35041062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.
    Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Rossi M; Polischi B; Capellari S; Parchi P
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
    Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
    J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.